Knight Therapeutics Argentina

Knight Therapeutics Argentina company information, Employees & Contact Information

Updated May 2026

Quick answer

Knight Therapeutics Argentina is a Pharmaceutical Manufacturing company and founded in 2014. It has approximately 234 employees on record. Contact data was last refreshed in May 2026. Find Knight Therapeutics Argentina's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Fundada en 1984, Biotoscana es una compañía biofarmacéutica líder en latinoamerica que se especializa en el tratamiento de enfermedades raras, generalmente fatales. Biotoscana cuenta con un portafolio de medicamentos innovadores para el tratamiento de la hipertensión arterial pulmonar, trastornos hereditarios metabólicos graves, trastornos inmunológicas relacionados con proteínas plasmáticas, así como tratamientos especiales para la enfermedad inflamatoria intestinal y enfermedad hepática colestásica. Biotoscana mantiene relaciones comerciales de larga data con compañías farmacéuticas líderes como Actelion, CSL Behring, Dr. Falk y otras. Con sede en Bogotá, Colombia; Biotoscana cuenta con operaciones propias en Argentina, Chile, Ecuador y Perú.

Company Details

Employees
234
Founded
2014
Address
Martin Lezica 3028, San Isidro,buenos Aires B1642gjb,argentina
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
San Isidro, Buenos Aires
Looking for a particular Knight Therapeutics Argentina employee's phone or email?

Knight Therapeutics Argentina Questions

News

Knight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth Platform - GlobeNewswire

Knight Therapeutics to Acquire Grupo Biotoscana, Establishing a Latin American Growth Platform GlobeNewswire

Knight Therapeutics makes ‘transformational’ acquisition in Brazil - The Pharma Letter

Knight Therapeutics makes ‘transformational’ acquisition in Brazil The Pharma Letter

FXCM President Robert Lande joins board of GBT Grupo Biotoscana - FX News Group

FXCM President Robert Lande joins board of GBT Grupo Biotoscana FX News Group

Knight Therapeutics Grupo Biotoscana acquisition is “transformational”, says GMP - Cantech Letter

Knight Therapeutics Grupo Biotoscana acquisition is “transformational”, says GMP Cantech Letter

Top Knight Therapeutics Argentina Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant